These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 4461994)
1. A modification of the activated partial thromboplastin time using ellagic acid and an EEL prothrombin meter. Morgan LO Med Lab Technol; 1974 Apr; 31(2):109-13. PubMed ID: 4461994 [No Abstract] [Full Text] [Related]
2. A comparison between two commercially available activators for determining the partial thromboplastin time. Smith LG; Kitchens CS Arch Pathol Lab Med; 1985 Mar; 109(3):243-6. PubMed ID: 2983635 [TBL] [Abstract][Full Text] [Related]
3. [Changes of the blood-pH and coagulation potential (author's transl)]. Neef H; Richter M; Fischer U Anaesthesist; 1974 Mar; 23(3):158-61. PubMed ID: 4460739 [No Abstract] [Full Text] [Related]
4. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs. Martini WZ; Dubick MA; Wade CE; Holcomb JB Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929 [TBL] [Abstract][Full Text] [Related]
5. [Rapid centrifugation for routine coagulation testing]. Boudaoud L; Divaret G; Marie P; Bezeaud A Ann Biol Clin (Paris); 2006; 64(4):315-7. PubMed ID: 16829473 [TBL] [Abstract][Full Text] [Related]
6. Interpreting partial thromboplastin times. Edson JR Minn Med; 1975 Nov; 58(11):833-4. PubMed ID: 1196277 [No Abstract] [Full Text] [Related]
12. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma. Teng HW; Chen PM; Yang YH; Gau JP Jpn J Clin Oncol; 2007 Aug; 37(8):609-14. PubMed ID: 17693643 [TBL] [Abstract][Full Text] [Related]
13. [Mixing test for prolonged clotting time: clinical availability and problems]. Uchiba M; Ando Y Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499 [TBL] [Abstract][Full Text] [Related]
14. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Greene CE; Meriwether E Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231 [TBL] [Abstract][Full Text] [Related]
15. [Studies on determination of partial thromboplastin time and prothrombin time using BBL fibrometer (author's transl)]. Hashizume K; Kawai K; Kane N; Fukuda R; Matsubara F Rinsho Byori; 1973 Aug; 21(8):721-4. PubMed ID: 4796721 [No Abstract] [Full Text] [Related]
16. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT). Peterson P; Gottfried EL Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228 [TBL] [Abstract][Full Text] [Related]
17. Laboratory management of the bleeding patient. Taylor LJ Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191 [No Abstract] [Full Text] [Related]
18. Effect of incubation time and anticoagulant on the activated partial thromboplastin time. Davis KD; Johnson MA Am J Med Technol; 1973 Apr; 39(4):136-9. PubMed ID: 4693799 [No Abstract] [Full Text] [Related]
19. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K]. Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200 [No Abstract] [Full Text] [Related]
20. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Huissoud C; Carrabin N; Benchaib M; Fontaine O; Levrat A; Massignon D; Touzet S; Rudigoz RC; Berland M Thromb Haemost; 2009 Apr; 101(4):755-61. PubMed ID: 19350122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]